After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.

Will big business determine a future filled with immunity passports and enforced vaccination? Will the public accept these passports

Medika Life 50 Top Healthcare Voices of Influence for 2022. Engage with leading voices, amplify their reach and expand your network.

Our foibles make us who we are, and perfection may not be what we want or need. What we want is to be understood, accepted, and helped when we need help.